tradingkey.logo
tradingkey.logo
Pesquisar

AtriCure Inc

ATRC
Adicionar à lista de desejos
31.307USD
+1.577+5.31%
Horário de mercado ETCotações atrasadas em 15 min
1.56BValor de mercado
PerdaP/L TTM

Mais detalhes de AtriCure Inc Empresa

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

Informações de AtriCure Inc

Código da empresaATRC
Nome da EmpresaAtriCure Inc
Data de listagemAug 05, 2005
CEOCarrel (Michael H)
Número de funcionários1300
Tipo de títulosOrdinary Share
Fim do ano fiscalAug 05
Endereço7555 Innovation Way
CidadeMASON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal45040
Telefone15137554100
Sitehttps://www.atricure.com
Código da empresaATRC
Data de listagemAug 05, 2005
CEOCarrel (Michael H)

Executivos da empresa AtriCure Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
796.06K
+12.20%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
158.05K
+20.54%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
128.32K
+4.79%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
106.40K
+25.94%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
96.05K
+28.63%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
91.88K
-5.44%
Mr. Sven A. Wehrwein, CPA
Mr. Sven A. Wehrwein, CPA
Independent Director
Independent Director
40.52K
+15.16%
Ms. Regina E. (Reggie) Groves
Ms. Regina E. (Reggie) Groves
Independent Director
Independent Director
39.86K
+15.41%
Ms. Deborah H. (Deb) Telman
Ms. Deborah H. (Deb) Telman
Independent Director
Independent Director
28.33K
+21.69%
Mr. Shlomo Nachman
Mr. Shlomo Nachman
Independent Director
Independent Director
24.66K
+24.92%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
796.06K
+12.20%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
158.05K
+20.54%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
128.32K
+4.79%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
106.40K
+25.94%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
96.05K
+28.63%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
91.88K
-5.44%

Perguntas frequentes

Quem são os cinco principais acionistas de AtriCure Inc?

Os cinco principais acionistas de AtriCure Inc são: Mr. Michael H. (Mike) Carrel, CPA

Quantas instituições possuem ações da AtriCure Inc (ATRC)?

Em 2026Q1, 505 instituições possuíam ações da AtriCure Inc, com valor de mercado aproximado de 48.18M, representando 95.14% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -7010307.00.

Qual é a maior fonte de receita da AtriCure Inc?

Em 2026Q1, o segmento de negócios Appendage Management-United states gerou a maior receita para AtriCure Inc, totalizando 178.13M e representando 33.32% da receita total.